Connection to Health for Smokers (CTHS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03680599 |
|
Recruitment Status :
Completed
First Posted : September 21, 2018
Last Update Posted : April 1, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Tobacco Use | Behavioral: Connection to Health for Smokers Behavioral: Enhanced Standard of Care | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 123 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Connection to Health for Smokers -- A Comprehensive Program to Reduce Tobacco-Related Health Disparities in CHCs |
| Actual Study Start Date : | January 3, 2019 |
| Actual Primary Completion Date : | March 31, 2020 |
| Actual Study Completion Date : | March 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Connection to Health for Smokers
Participants in this arm will participate in the Connection to Health for Smokers Arm of the study, wherein an electronic survey will be administered and participants will be guided through an evidence-based action planning sequence, taking into account each patient's unique social environment, health related behaviors, and behavioral health status, with multimodal follow up.
|
Behavioral: Connection to Health for Smokers
Connection to Health for Smokers includes 5 core components supported by online tools: (1) comprehensive electronic patient survey, (2) automated summary report to flag areas of difficulty (3) interactive priority setting, (4) interactive action planning, and (5) electronic text reminders and followup. |
|
Active Comparator: Enhanced Standard of Care
Participants in this arm will participate in Enhanced Standard Care, wherein participants will receive a brief electronic survey and receive standard smoking cessation program that does not include formal action planning and multimodal follow up.
|
Behavioral: Enhanced Standard of Care
Participants will complete a survey and receive standard one-on-one smoking cessation according to a usual care protocol delivered by health educators |
- Program Reach, Effectiveness, Adoption, Implementation, and Maintenance [ Time Frame: 3 months ]The RE-AIM Framework will be used to assess program feasibility
- 7-day smoking abstinence [ Time Frame: 3 months ]Not smoking cigarettes (not even a puff) in the last 7 days
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Must have smoked cigarettes in the last 7 days
Exclusion Criteria:
- Speaking languages other than English or Spanish
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03680599
| United States, California | |
| University of California, San Francisco | |
| San Francisco, California, United States, 94143 | |
| Principal Investigator: | Michael Potter, M.D. | University of California, San Francisco |
| Responsible Party: | University of California, San Francisco |
| ClinicalTrials.gov Identifier: | NCT03680599 |
| Other Study ID Numbers: |
27IP-0024 |
| First Posted: | September 21, 2018 Key Record Dates |
| Last Update Posted: | April 1, 2020 |
| Last Verified: | March 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

